MRI features of posterior reversible encephalopathy syndrome in 33 patients

Journal of Neuroimaging

Volumn 20, Issue 1, 2010, Pages 22-28

  Donmez, Fuldem Y ^a   Basaran, Ceyla ^a   Kayahan Ulu, Esra M ^a   Yildirim, Mahir ^a   Coskun, Mehmet ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Brain; Diffusion weighted imaging; MRI; Posterior reversible encephalopathy

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BLEEDING; BRAIN EDEMA; CEREBELLUM; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; FEMALE; FRONTAL LOBE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; OSTEOSARCOMA; PARIETAL LOBE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; TEMPORAL LOBE; AGE; BRAIN; BRAIN DISEASES; COMPLICATION; FOLLOW UP; MIDDLE AGED; NERVE TRACT; PATHOLOGY; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYNDROME; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BRAIN; BRAIN DISEASES; CHILD; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURAL PATHWAYS; RETROSPECTIVE STUDIES; SEX FACTORS; SYNDROME; YOUNG ADULT;

EID: 74049129458     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2008.00306.x     Document Type: Article

References (26)

1. Pande AR, Ando K, Ishikura R, et al. Clinicoradiological factors influencing the reversibility of posterior reversible encephalopathy syndrome: a multicenter study. Radiat Med 2006 24 : 659 668.
2. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996 334 : 494 500.
3. Brubaker LM, Smith JK, Lee YZ, et al. Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging. Am J Neuroradiol 2005 26 : 825 830.
4. Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor imaging. Radiology 2001 219 : 756 765.
5. Bartynski WS, Boardman JF, Zeigler ZR, et al. Posterior reversible encephalopathy syndrome in infection, sepsis and shock. Am J Neuroradiol 2006 27 : 2179 2190.
6. Lamy C, Oppenheim C, Méder JF, et al. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 2004 14 : 89 96.
7. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible ebcephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. Am J Neuroradiol 2002 23 : 1038 1048.
8. Bianco F. Reversible posterior leukoencephalopathy syndrome: a changing concept. Neuroradiology 2005 47 : 703 704.
9. Narbone MC, Musolino R, Granata F, et al. PRES: posterior or potentially reversible encephalopathy syndrome? Neurol Sci 2006 27 : 187 189.
10. Onder AM, Lopez R, Teomete U, et al. Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol 2007 22 : 1921 1929.
11. Ishimori ML, Pressman BD, Wallace DJ, et al. Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE? Lupus 2007 16 : 436 443.
12. Aydin K, Donmez F, Tuzun U, et al. Diffusion MR findings in cyclosporin-A induced encephalopathy. Neuroradiology 2004 46 : 822 824.
13. Ozkan A, Hakyemez B, Ozkalemkas F, et al. Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy. Neuroradiology 2006 48 : 887 892.
14. Lux P, Ringelstein A, Hunerliturkoglu A, et al. Tacrolimus-induced encephalopathy in radiology. Clin Neuroradiol 2007 17 : 198 201.
15. Renard D, Westhovens R, Vandenbussche E, et al. Reversible posterior leukoencephalopathy during oral treatment with metotrexate. J Neurol 2004 251 : 226 228.
16. Doelken M, Lanz S, Rennert J, et al. Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI. Diagn Interv Radiol 2007 13 : 125 128.
17. Delanty N, Vaughan CJ. Seizures, hypertension, and posterior leukoencephalopathy. In Delanty N ed Seizures: Medical Causes and Management. Totowa, NJ : Human Press, 2002 251 260.
18. Port JD, Beauchamp NJ. Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 1998 18 : 353 367.
19. Ahn KJ, You WJ, Jeong SL, et al. Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology 2004 46 : 978 983.
20. Kitaguchi H, Tomimoto H, Miki Y, et al. A brainstem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology 2005 47 : 652 656.
21. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. Am J Roentgenol 2007 189 : 904 912.
22. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. Am J Neuroradiol 2007 28 : 1320 1327.
23. Ay H, Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998 51 : 1369 1376.
24. Tamaki K, Sadoshima S, Baumbach GL, et al. Evidence that disruption of the blood-brain-barrier precedes reduction in cerebral blood flow in hypertensive encephalopathy. Hypertension 1984 6 : I75 I81.
25. Ugurel MS, Hayakawa M. Implications of post-gadolinium MRI results in 13 cases with posterior reversible encephalopathy syndrome. Eur J Radiology 2005 53 : 441 449.
26. Sweany JM, Bartynski WS, Boardman JF. "Recurrent" posterior reversible encephalopathy syndrome: report of 3 cases-PRES can strike twice J Comput Assist Tomogr 2007 31 : 148 156.